dc.contributor.author | Ergen, Arzu | |
dc.contributor.author | Iplik, E. Sinem | |
dc.contributor.author | Ertugrul, Baris | |
dc.contributor.author | Atas, Merve Nur | |
dc.contributor.author | Kasarci, Goksu | |
dc.contributor.author | Cakmakoglu, Bedia | |
dc.date.accessioned | 2021-12-21T08:45:51Z | |
dc.date.available | 2021-12-21T08:45:51Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 1309-9469 | |
dc.identifier.uri | https://doi.org/10.5472/marumj.815542 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1795 | |
dc.description.abstract | Objective: Renal cancers are highly resistant to standard hormonal therapy, radiotherapy, and chemotherapy, and the survival rates are extremely low. Betulinic acid is a pentasilic triterpenoid saponin of lupine type obtained from various natural plants, | |
dc.description.sponsorship | Scientific Research Projects Coordination Unit of Istanbul UniversityIstanbul University [23450] | |
dc.language.iso | English | |
dc.publisher | Marmara Unıv, Fac Medıcıne | |
dc.rights | gold | |
dc.title | Examination of the apoptotic effects of betulinic acid on renal cancer cell lines | |
dc.type | Article | |
dc.relation.journal | Marmara Medıcal Journal | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 113 | |
dc.identifier.endpage | 118 | |
dc.identifier.volume | 33 | |
dc.identifier.doi | 10.5472/marumj.815542 | |
dc.relation.issue | 3 | |
dc.relation.volume | 33 | |